Factors Associated with Severity of Alopecia Areata
2
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Background: Alopecia areata is the most common cause of localized, nonscarring alopecia. Unfortunately, there are few data regarding clinical features and epidemiology of alopecia areata in Korean patients, and its clinical course and treatment response rates are unpredictable. Objective: This study strived to investigate the differences in clinical profiles according to disease severity and to determine risk factors for severe alopecia areata. Methods: A total of 1,137 patients from 2006 to 2015 were analyzed retrospectively. Patients were subdivided into two groups: mild-to-moderate and severe alopecia areata. The groups were compared on the basis of age of onset, duration, sex, family history, comorbid disorders including autoimmune diseases, nail changes, and laboratory test results. Results: Eight hundred eighty-three patients were in the mild-to-moderate alopecia areata group and 254 patients were in the severe group. Average onset age was 30.77±17.66 years and 30.60±16.75 years in the mild-to-moderate and severe groups, respectively. Disease duration was statistically longer in the severe group. Male sex, nail changes, and thyroid diseases were more common in the severe group. Hypertension, diabetes mellitus, dyslipidemia, atopic dermatitis, and family history did not differ between groups. Of the serologic values, only alkaline phosphatase was considerably differing between groups. Male sex, presence of nail changes, and disease duration greater than one year were identified as significant risk factors for severe alopecia areata. Conclusion: This is the largest case analysis in Korean patients with alopecia areata. Clinical profiles stratified by disease severity warrant further study.
Abstract
Background: Alopecia areata is the most common cause of localized, nonscarring alopecia. Unfortunately, there are few data regarding clinical features and epidemiology of alopecia areata in Korean patients, and its clinical course and treatment response rates are unpredictable. Objective: This study strived to investigate the differences in clinical profiles according to disease severity and to determine risk factors for severe alopecia areata. Methods: A total of 1,137 patients from 2006 to 2015 were analyzed retrospectively. Patients were subdivided into two groups: mild-to-moderate and severe alopecia areata. The groups were compared on the basis of age of onset, duration, sex, family history, comorbid disorders including autoimmune diseases, nail changes, and laboratory test results. Results: Eight hundred eighty-three patients were in the mild-to-moderate alopecia areata group and 254 patients were in the severe group. Average onset age was 30.77±17.66 years and 30.60±16.75 years in the mild-to-moderate and severe groups, respectively. Disease duration was statistically longer in the severe group. Male sex, nail changes, and thyroid diseases were more common in the severe group. Hypertension, diabetes mellitus, dyslipidemia, atopic dermatitis, and family history did not differ between groups. Of the serologic values, only alkaline phosphatase was considerably differing between groups. Male sex, presence of nail changes, and disease duration greater than one year were identified as significant risk factors for severe alopecia areata. Conclusion: This is the largest case analysis in Korean patients with alopecia areata. Clinical profiles stratified by disease severity warrant further study.
참고문헌 (30)
- Alkhalifah A, "Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis", J Am Acad Dermatol, 62, pp.177~188 (2010)
- Assouly P, "Intravenous pulse methylprednisolone therapy for severe alopecia areata: an open study of 66patients", Ann Dermatol Venereol, 130, pp.326~330 (2003)
- Gilhar A, "Alopecia areata", N Engl J Med, 366, pp.1515~1525 (2012)
- Kakourou T, "A case series of alopecia areata in children: impact of personal and family history of stress and autoimmunity", J Eur Acad Dermatol Venereol, 21, pp.356~359 (2007)
- Chu SY, "Comorbidity profiles among patients with alopecia areata: the importance of onset age, a nationwide populationbased study", J Am Acad Dermatol, pp.949~956 (2011)
- Friedmann PS, "Alopecia areata and auto-immunity", Br J Dermatol, 105, pp.153~157 (1981)
- Safavi KH, "Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989", Mayo Clin Proc, 70, pp.628~633 (1995)
- Olsen E, "Alopecia areata investigational assessment guidelines. National Alopecia Areata Foundation", J Am Acad Dermatol, 40, pp.242~246 (1999)
- Tosti A, "Alopecia areata: a long term follow-up study of 191 patients", J Am Acad Dermatol, 55, pp.438~441 (2006)
- van der Steen PH, "Prognostic factors in the treatment of alopecia areata with diphenylcyclopropenone", J Am Acad Dermatol, 24, pp.227~230 (1991)
- Sharma VK, "Profile of alopecia areata in Northern India", Int J Dermatol, 35, pp.22~27 (1996)
- Xiao FL, "The epidemiology of childhood alopecia areata in China: a study of 226 patients", Pediatr Dermatol, 23, pp.13~18 (2006)
- Tan E, "A clinical study of childhood alopecia areata in Singapore", Pediatr Dermatol, 19, pp.298~301 (2002)
- 박민수, "원형 탈모증의 예후 인자 고찰", 대한피부과학회지, 42(7), pp.825~832 (2004), 대한피부과학회
- Tan E, "The pattern and profile of alopecia areata in Singapore--a study of 219Asians", Int J Dermatol, 41, pp.748~753 (2002)
- De Waard-van der Spek FB, "Juvenile versus maturity-onset alopecia areata--a comparative retrospective clinical study", Clin Exp Dermatol, 14, pp.429~433 (1989)
- 이누리, "Differences in Comorbidity Profiles between Early-Onset and Late-Onset Alopecia Areata Patients: A Retrospective Study of 871 Korean Patients", Annals of Dermatology, 26(6), pp.722~726 (2014), 대한피부과학회
- Muller SA, "Alopecia areata. An evaluation of 736 patients", Arch Dermatol, 88, pp.290~297 (1963)
- Sharma VK, "Nail changes in 1000 Indian patients with alopecia areata", J Eur Acad Dermatol Venereol, 10, pp.189~191 (1998)
- Mustonen T, "Stimulation of ectodermal organ development by Ectodysplasin-A1", Dev Biol, 259, pp.123~136 (2003)
- Chao-Chun Yang, "Early Intervention with High-Dose Steroid Pulse Therapy Prolongs Disease-Free Interval of Severe Alopecia Areata:A Retrospective Study", Annals of Dermatology, 25(4), pp.471~474 (2013), 대한피부과학회
- Bertolini M, "Alopecia areata as a model for T cell-dependent autoimmune diseases", Exp Dermatol, 21, pp.477~479 (2012)
- Alexis AF, "Alopecia areata: autoimmune basis of hair loss", Eur J Dermatol, 14, pp.364~370 (2004)
- Gilhar A, "Lymphocytes, neuropeptides, and genes involved in alopecia areata", J Clin Invest, 117, pp.2019~2027 (2007)
- Hahnel AC, "Two alkaline phosphatase genes are expressed during early development in the mouse embryo", Development, 110, pp.555~564 (1990)
- Li L, "Skin histoculture assay for studying the hair cycle", In Vitro Cell Dev Biol, 28, pp.695~698 (1992)
- Manes T, "Genomic structure and comparison of mouse tissue-specific alkaline phosphatase genes", Genomics, 8, pp.541~554 (1990)
- White MI, "A study of the tissue iron status of patients with alopecia areata", Br J Dermatol, 130, pp.261~263 (1994)
- Boffa MJ, "Iron status of patients with alopecia areata", Br J Dermatol, 132, pp.662~664 (1995)
- Gonul M, "Serum vitamin B12, folate, ferritin, and iron levels in Turkish patients with alopecia areata", Indian J Dermatol Venereol Leprol, 75, pp.552~ (2009)